111
|
|
|
Ral guanine nucleotide dissociation stimulator |
RGDS, RGF, RalGEF |
|
112
|
|
|
Ral GEF with PH domain and SH3 binding motif 1 |
RALGEF2, RALGPS1A |
|
113
|
|
|
Ral GEF with PH domain and SH3 binding motif 2 |
dJ595C2.1 |
|
114
|
|
|
RALY heterogeneous nuclear ribonucleoprotein |
HNRPCL2, P542 |
Amphetamine or sympathomimetic abuse, Attention deficit hyperactivity disorder, Basal cell carcinoma, Biliary tract cancer, Breast cancer, Cancer, Cervical cancer, Colorectal cancer, Melanoma, Cutaneous squamous cell carcinoma, Dilated cardiomyopathy, Endometrial cancer, Erythematosquamous dermatosis, Esophageal cancer, Estrogen-receptor negative breast cancer, Gastric cancer, Hepatocellular carcinoma, Keratinocyte carcinoma, Lung cancer, Non-hodgkins lymphoma, Non-melanoma skin carcinoma, Non-small cell lung carcinoma, Ovarian cancer, Ovarian serous carcinoma, Pancreatic cancer, Prostate cancer, Sebaceous gland disease, Seborrheic dermatitis, Seborrheic keratosis, Skin cancer, Skin disease, Skin neoplasms, Squamous cell carcinoma, Diabetes mellitus type 2, VitiligoView all (20 more) |
115
|
|
|
RALY RNA binding protein like |
HNRPCL3 |
|
116
|
|
|
RNA guanine-7 methyltransferase activating subunit like |
C6orf119, FAM103A2P, RAMMETL, RAMMETP1, dJ427A4.2 |
|
117
|
|
|
Receptor activity modifying protein 1 |
- |
|
118
|
|
|
Receptor activity modifying protein 2 |
- |
|
119
|
|
|
Receptor activity modifying protein 3 |
- |
|
120
|
|
|
RAN, member RAS oncogene family |
ARA24, Gsp1, TC4 |
|